RBLY vs. FTXH

Last updated Jun 4, 2026

RBLY (YieldMax RBLX Option Income Strategy ETF) and FTXH (First Trust Nasdaq Pharmaceuticals ETF) are both exchange-traded funds - RBLY is a Derivative Income fund actively managed by YieldMax, while FTXH is a Health & Biotech Equities fund tracking the Nasdaq U.S. Smart Pharmaceuticals Index. RBLY is actively managed, while FTXH is passively managed. At a correlation of -0.10, they often move in opposite directions. RBLY charges 0.99%/yr vs 0.60%/yr for FTXH.

Performance

RBLY vs. FTXH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in YieldMax RBLX Option Income Strategy ETF (RBLY) and First Trust Nasdaq Pharmaceuticals ETF (FTXH). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, RBLY achieves a -45.56% return, which is significantly lower than FTXH's 5.00% return.

RBLY

• 1D: -1.83%
• 1M: -8.47%
• YTD: -45.56%
• 6M: -50.91%
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

FTXH

• 1D: 1.69%
• 1M: 1.65%
• YTD: 5.00%
• 6M: 6.02%
• 1Y: 36.24%
• 3Y*: 11.48%
• 5Y*: 7.80%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

RBLY vs. FTXH - Yearly Performance Comparison

	2026 (YTD)	2025
RBLY YieldMax RBLX Option Income Strategy ETF	-45.56%	-24.82%
FTXH First Trust Nasdaq Pharmaceuticals ETF	5.00%	24.83%

Correlation

The correlation between RBLY and FTXH is -0.10, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.

	Correlation
Correlation (All Time) Calculated using the full available price history since Jul 30, 2025	-0.11

Return for Risk

RBLY vs. FTXH — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

FTXH

FTXH Risk / Return Rank: 71
FTXH Sharpe Ratio Rank: 64
FTXH Sortino Ratio Rank: 69
FTXH Omega Ratio Rank: 60
FTXH Calmar Ratio Rank: 87
FTXH Martin Ratio Rank: 74

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

RBLY vs. FTXH - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for YieldMax RBLX Option Income Strategy ETF (RBLY) and First Trust Nasdaq Pharmaceuticals ETF (FTXH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	RBLY	FTXH	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	2.14	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	0.48	—
Sharpe Ratio (All Time) Calculated using the full available price history	-1.25	0.38	-1.62

Drawdowns

RBLY vs. FTXH - Drawdown Comparison

The maximum RBLY drawdown since its inception was -65.81%, which is greater than FTXH's maximum drawdown of -32.11%. Use the drawdown chart below to compare losses from any high point for RBLY and FTXH.

Drawdown Indicators

	RBLY	FTXH	Difference
Max Drawdown Largest peak-to-trough decline	-65.81%	-32.11%	-33.70%
Max Drawdown (1Y) Largest decline over 1 year	—	-7.47%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-19.51%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-19.51%	—
Current Drawdown Current decline from peak	-65.42%	-2.88%	-62.54%
Average Drawdown Average peak-to-trough decline	-33.05%	-5.84%	-27.21%
Ulcer Index Depth and duration of drawdowns from previous peaks	—	2.58%	—

Volatility

Volatility by Period

	RBLY	FTXH	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	4.83%	—
Volatility (6M) Calculated over the trailing 6-month period	—	11.73%	—
Volatility (1Y) Calculated over the trailing 1-year period	52.41%	16.98%	+35.43%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	52.41%	16.31%	+36.10%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	52.41%	18.41%	+34.00%

RBLY vs. FTXH - Expense Ratio Comparison

RBLY has a 0.99% expense ratio, which is higher than FTXH's 0.60% expense ratio.

Dividends

RBLY vs. FTXH - Dividend Comparison

RBLY's dividend yield for the trailing twelve months is around 127.58%, more than FTXH's 1.22% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
FTXH First Trust Nasdaq Pharmaceuticals ETF	1.22%	1.41%	1.66%	1.55%	1.11%	1.03%	0.82%	0.67%	0.91%	2.18%	0.19%
RBLY YieldMax RBLX Option Income Strategy ETF	127.58%	36.84%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both RBLY and FTXH in my portfolio?

RBLY and FTXH have a correlation of -0.10, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which ETF is better, RBLY or FTXH?

On fees, FTXH is cheaper at 0.60% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, RBLY or FTXH?

FTXH is cheaper with a 0.60% expense ratio, compared with 0.99% for RBLY.

Which ETF pays a higher dividend yield, RBLY or FTXH?

RBLY has the higher dividend yield at 127.58%, compared with 1.22% for FTXH.

What is the main difference between RBLY and FTXH?

RBLY is categorized as Derivative Income, while FTXH is Health & Biotech Equities. They also come from different issuers: YieldMax and First Trust. Their fees differ too: 0.99% for RBLY and 0.60% for FTXH.